全文获取类型
收费全文 | 299篇 |
免费 | 13篇 |
国内免费 | 4篇 |
专业分类
儿科学 | 11篇 |
妇产科学 | 2篇 |
基础医学 | 16篇 |
口腔科学 | 13篇 |
临床医学 | 21篇 |
内科学 | 66篇 |
皮肤病学 | 1篇 |
神经病学 | 3篇 |
特种医学 | 91篇 |
外科学 | 23篇 |
综合类 | 18篇 |
预防医学 | 15篇 |
眼科学 | 2篇 |
药学 | 12篇 |
肿瘤学 | 22篇 |
出版年
2021年 | 4篇 |
2020年 | 4篇 |
2019年 | 3篇 |
2018年 | 6篇 |
2017年 | 4篇 |
2016年 | 5篇 |
2015年 | 12篇 |
2014年 | 6篇 |
2013年 | 18篇 |
2012年 | 10篇 |
2011年 | 2篇 |
2010年 | 15篇 |
2009年 | 9篇 |
2008年 | 9篇 |
2007年 | 6篇 |
2006年 | 4篇 |
2005年 | 4篇 |
2004年 | 4篇 |
2001年 | 2篇 |
2000年 | 3篇 |
1999年 | 3篇 |
1998年 | 18篇 |
1997年 | 20篇 |
1996年 | 16篇 |
1995年 | 12篇 |
1994年 | 14篇 |
1993年 | 9篇 |
1991年 | 4篇 |
1990年 | 6篇 |
1989年 | 10篇 |
1988年 | 5篇 |
1987年 | 4篇 |
1986年 | 7篇 |
1985年 | 5篇 |
1984年 | 6篇 |
1982年 | 3篇 |
1981年 | 5篇 |
1980年 | 8篇 |
1978年 | 5篇 |
1977年 | 5篇 |
1976年 | 3篇 |
1975年 | 4篇 |
1973年 | 1篇 |
1968年 | 1篇 |
1966年 | 1篇 |
1960年 | 1篇 |
1958年 | 2篇 |
1954年 | 2篇 |
1953年 | 2篇 |
1952年 | 1篇 |
排序方式: 共有316条查询结果,搜索用时 31 毫秒
111.
Background: Stress fracture is the single most common cause for the lost number of manpower days during training. The conventional treatment options begin with rest and cessation of precipitating activity. However the demands of military training provide little tolerance for prolonged periods of rest. In the recent past ultrasound therapy (UST) has been reported to speed up healing of stress fractures. 相似文献
112.
113.
ObjectiveTo study anxiolytic property of hydro alchohol extract and to estimate polyphenols present in the extract by HPLC.MethodsTo evaluate anxiolytic property two animal models were used viz. Elevated T maze and hyponeophagia. Diazepam (1 mg/kg body wt.) served as the standard anxiolytic agent for all the tests. The dried extract of the plant leaf in doses of 100, 200 and 400 mg/kg body weight was administered orally to mice for duration of 15 or 30 days and locomotor and anxiolytic activities were performed. Polyphenols was estimated using HPLC.ResultsThe HPLC analysis of the polyphenols revealed the presence chlorogenic acid, vanillin, epicatechin, caffeic acid, rutin hydrate, sinapic acid, quercetin-3-rhamnoside, p-coumeric acid and quercitin. Time spent and number of entries into the open arm was improved in 30 days treated animals than that of 15 days treated groups, 200 and 400 mg/kg body weight treated group showed significant results when comparing with the control group.ConclusionsThe hydro alcohol extract rich in Polyphenols and other secondary metabolites is a potent anxiolytic agent. 相似文献
114.
115.
116.
117.
KR JULIAN CHUN M.D. STEFANO BORDIGNON M.D. MELANIE GUNAWARDENE VERENA URBAN M.D. MEHMET KULIKOGLU M.D. BRITTA SCHULTE‐HAHN M.D. BERND NOWAK M.D. BORIS SCHMIDT M.D. 《Pacing and clinical electrophysiology : PACE》2012,35(11):1304-1311
Background: The single big cryoballon technique for pulmonary vein isolation (PVI) has been limited by the need for two transseptal punctures (TP). We therefore investigated feasibility and safety of a simplified approach using a single TP and a novel circumferential mapping catheter (CMC). Methods: Patients underwent 28‐mm cryoballoon PVI using a single TP. The CMC (Achieve© Medtronic Inc., Minneapolis, MN, USA) served as (1) guidewire and (2) as a PV mapping tool. Primary endpoint was PVI without switching to a regular guidewire. Secondary endpoints included: (1) PV signal quality during freezing, (2) time to PVI, (3) classification of successful ablation technique, (4) complications, and (5) procedural data. Results: A total of 32 patients (126 PVs) were studied (mean age: 62 ± 11 years, 24 males, left atrium: 40 ± 4 mm). The primary endpoint was achieved in 29/32 patients (91%) and 123/126 PVs (98%) with a procedure and fluoroscopy time of 126 ± 26 minutes and 18.9 ± 7.5 minutes, respectively. Real‐time visualization of PVI could be observed in 61/126 (48%) PVs. Time to sustained PVI versus nonsustained PVI was 66 ± 56 seconds versus 129 ± 76 seconds (P < 0.001). One phrenic nerve palsy was observed. After a follow‐up of 250 ± 84 days 23/32 patients (72%) remained in sinus rhythm. Conclusion: The “simplified single big cryoballoon” PVI strategy appears to be safe and feasible. However, real‐time PV recording was achieved in <50% of PVs. Therefore, further catheter refinements are warranted. (PACE 2012; 35:1304–1311) 相似文献
118.
Deepak Gopalakrishnan Mark Keyter Kotacherry Trivikrama Shenoy Kondarappassery Balakumaran Leena Lakshmikanthan Thayumanavan Varghese Thomas KR Vinayakumar Charles Panackel Arun T Korah Ramesh Nair Anna Kramvis 《World journal of gastroenterology : WJG》2013,19(48):9294-9306
AIM:To molecularly characterize hepatitis B virus(HBV)isolates from Kerala and to relate them to the clinical manifestation of infection.METHODS:Sera and clinical data were collected from91 patients diagnosed with chronic HBV infection and HBV-related hepatocellular carcinoma(HCC).HBV from44 HCC,22 cirrhotic and 25 chronic hepatitis patients were genotyped by sequencing of the complete S region or by restriction fragment length polymorphism assays.The basic core promoter/precore region was sequenced.The complete surface DNA sequences were assembled and aligned manually,and then compared with the sequences of HBV of genotypes(A-J)from GenBank.The evolutionary history was inferred using the Neighbor-Joining method and the evolutionary distances computed using the Kimura 2-parameter method.Bootstrapping was performed using 1000 replicates.The TaqMan BS-1 probe was used to quantify HBV DNA at a lower detection limit of approximately20 IU/mL.Continuous variables were compared using an independent Student’s t test.Theχ2test or Fisher’s exact test was used to compare categorical variables.The differences were considered statistically significant at P<0.05.RESULTS:Irrespective of disease status,the predominant genotype was A(72%);95%belonging to subgenotype A1,followed by genotypes D(27%)and C(1%).HCC patients infected with subgenotype A1were significantly younger than those infected with D.Mutation A1762T/G1764A was significantly associated with HCC in both genotypes A and D.Mutation G1862T was more frequent in subgenotype A1(P<0.0001),and in combination with A1762T/G1764A,it was significantly associated with HBV from HCC patients.Mutation C1766T/T1768A was significantly associated with genotype A(P=0.05)and HCC(P=0.03).The preS2start codon M1T/I mutation was unique to genotype A strains(15.6%)from all disease groups and occurred at a higher frequency in isolates from HCC patients(P=0.076).A higher frequency of preS deletion mutants(33.3%)was observed in genotype A from HCC compared with non-HCC patients,but 相似文献
119.
M. N. TRAME L. MITCHELL A. KRÜMPEL C. MALE G. HEMPEL U. NOWAK‐GÖTTL 《Journal of thrombosis and haemostasis》2010,8(9):1950-1958
Summary. Background: Enoxaparin has been extensively studied in adults on its safety and efficacy during prevention of symptomatic thromboembolism when acute anticoagulation or secondary prevention is required as a result of venous thrombosis or stroke. In children, it is still used off‐label and little is known about the pharmacokinetics in children. Objectives: The aim of the present study was to evaluate whether a once‐ or twice‐daily dosing regimen would be feasible in children to achieve appropriate plasma levels of enoxaparin. Patients/methods: A population pharmacokinetic model was developed using anti‐factor (F)Xa activity data from 126 children (median age: 5.9 years) receiving enoxaparin either as a once‐ or twice‐daily dosing regimen. Results: A two‐compartment model was adequate for describing the enoxaparin kinetics. Body weight proved to be the most predictive covariate for clearance and central volume of distribution: clearance 15 mL h?1 kg?1, central volume of distribution 169 mL kg?1, intercompartmental clearance 58 mL h?1, peripheral volume of distribution 10 L and absorption rate 0.414 h?1. Interindividual variability was found to be 54% for clearance and 42% for volume of distribution. Conclusion: The model is capable of describing all age groups and dosing levels of our population and predicts 12 h and 24 h enoxaparin activities sufficiently. According to our results, a once‐daily enoxaparin dosing regimen with frequent monitoring is feasible. In 53.2% of the patients the median 24 h trough level was above the desired range of 0.1 IU mL?1 anti‐FXa activity for prophylaxis therapy. 相似文献
120.
Sujoy Ghosh Sarita Bajaj Kaushik Pandit Sanjay Agarwal SR Aravind Rajeev Chawla Sunil Gupta J Jayaprakashsai Sanjay Kalra Ch Vasanth Kumar Anuj Maheshwari BM Makkar CR Anand Moses Jayanta Panda Vijay Panikar PV Rao Banshi Saboo Rakesh Sahay KR Narasimha Setty Vijay Viswanathan 《International journal of diabetes in developing countries.》2017,37(4):400-406
More than 69 million Indians are suffering from diabetes, of which a substantial proportion of the population are currently holding or will seek in the future the license to drive. Driving essentially requires multitasking with visuospatial skills at the same time and thus the management of diabetes in individuals which should demonstrate a proper detection and treatment of diabetes-related hypoglycemia will predict the capacity of driving any motor vehicle. Repeated hypoglycemia-related neuroglycopenia causes increased risk of neurocognitive dysfunction leading to visuospatial skills deficiency. Eight percent of dementia may be attributed to diabetes. Potential causes of driving impairment associated with diabetes are acute hypoglycemia, and its unawareness, retinopathy, neuropathy related to foot that affects ability to use pedals, IHD, cerebrovascular disease, somnolence and sleep disorder associated with obesity, use of pain relieving medications and antidepressant, and cognitive dysfunction and thus should be reviewed properly before issuing a driving license. Medical evaluation and documentation of acute and chronic complications of drivers by a registered medical practitioner at pre-determined intervals may be considered as a legal necessity to identify at-risk drivers. Secretagogues have a higher incidence of hypoglycemia compared to someone who is on metformin alone. On the other hand, hypoglycemia is more frequent in an insulin-treated patient of both type 1 and type 2 diabetes. In many countries as well as in European Union (EU), it is necessary to review medical fitness in every 3 years by the authority; a person should not have any severe hypoglycemic event in preceding 12 months and a driver must have awareness of hypoglycemia and its management. According to Canadian diabetes association consensus statement, review should be done every 2 years; a person should not have any severe hypoglycemic event in preceding 6 months, and according to ADA position statement evaluation should be done every 2–5 years. Medical fitness certificate should be reviewed at frequent intervals; the authorities should enforce strict regulation on suspension and revocation of driving license. Information to the authorities should be promptly done by doctors or patients. Decision should be based on medical evaluation, but hypoglycemia that occurs due to medication change and during sleep does not warrant for disqualification as it may be corrected with proper dietary changes and dose adjustments. Any driver with suspended license should be re-assessed in the next 6 months for their medical fitness and hypoglycemic profile and if found suitable, the license can be revoked. Physicians should participate and should assess patient’s physical and mental status, medical condition and treatment, list of medications which may impair driving performance, and any disease-related complication that lead to impaired driving or dangerous driving. Patient education is the most important factor to prevent any motor accident related to their medical condition and should be trained to prevent acute and chronic complications of diabetes. 相似文献